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Abstract In response to the confirmed transmission of
hepatitis B virus (HBV) from a surgeon to several patients
in the Netherlands, a ‘Committee for Prevention of Iatrogenic
Hepatitis B’ was established in 2000. During the years 2000–
2008, the committee reviewed 99 cases of HBV-infected
health care workers. Fifty of them were found to perform
exposure prone procedures (EPPs). Because of high levels of
HBV DNA (>100,000 copies/ml), a ban on performing EPPs
was applied in 11/50 cases; 25/50 low-viremic health care
workers were allowed to continue EPPs while their HBV load
wasbeingmonitored;and14/50caseshadstoppedworkingor
changedprofession.Infiverestrictedworkerswhostartedoral
antiviral treatment, HBV replication was persistently sup-
pressed,enablingthebanonEPPstobelifted.Throughoutthe
European Union different levels of HBV viremia have been
chosen, above which health care workers are not allowed to
perform EPPs. It remains unknown how this affects the safety
of patients. Application in the Netherlands of a European or a
British guideline would have, respectively, doubled or tripled
t h en u m b e ro fr e s t r i c t e dh e a l t hc a r ew o r k e r s .
Introduction
In 1999, a Dutch surgeon transmitted hepatitis B virus
(HBV) to at least eight patients and possibly to a total of 28
patients [1]. Literature shows that this form of transmission
is not unique, numerous cases of HBV transmission from
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reviewed by Mele and Gunson [2, 3]. In 2000, the Dutch
Health Care Inspectorate established the ‘Commissie
Preventie Iatrogene Hepatitis B’ (Committee for Prevention
of Iatrogenic Hepatitis B; hereinafter referred to as the
Committee). The Committee was asked (1) to review all
HBV-infected health care workers in the Netherlands who
potentially perform exposure prone procedures (EPPs) and
to advise them on how to prevent transmission; and (2) to
develop a national guideline for the prevention of trans-
mission of HBV from health care workers to patients. The
guideline on prevention of iatrogenic hepatitis B was
published in June 2002 and was subsequently endorsed by
the Dutch Health Council [4]. In 2003 a European consensus
guideline became available [3]. Since 2003 national guide-
lines for the management of infected health care workers
have been instituted in several countries, as reviewed during
a meeting of the Viral Hepatitis Prevention Board in 2005
[5].
To prevent iatrogenic transmission of HBV, the Dutch
guideline states that the HBV status of all medical
personnel performing EPPs must be known. The definition
of EPPs was adopted from a report of the UK Health
Advisory Group [6]. This report defines EPPs as follows:
"Exposure prone procedures (EPPs) are those where there
is a risk that injury to the worker may result in exposure of
the patient’s open tissues to the blood of the worker. These
procedures include those where the worker’s gloved hands
may be in contact with sharp instruments, needle tips or
sharp tissues (spicules of bone or teeth) inside a patient’s
open body cavity, wound or confined anatomical space
where the hands or fingertips may not be completely visible
at all times."
In all but one case of reported HBV transmission to a
patient, the level of HBV viremia in the health care worker
was higher than 100,000 copies/ml [3, 7]. Balancing the
risk of HBV transmission and the loss of medical special-
ists, the HBV DNA threshold level above which the
Dutch guideline prohibits EPPs was chosen to be 100,000
copies/ml. In an HBV-infected person who performs
EPPS, it has to be demonstrated twice yearly that the HBV
viremia remains below this threshold. Antiviral maintenance
therapy using HBV polymerase inhibitors may successfully
suppress the level of HBV DNA below 100,000 copies/ml. In
this situation the level of HBV viremia in the health care
worker must be monitored every three months.
To ensure proper management of HBV-infected health
care workers, and to help decide whether a procedure is
exposure proneornot,intheNetherlandseveryHBV-infected
health care worker potentially performing EPPs must be
reported to the Committee for evaluation and advice. To
facilitate reporting, a local official may report an anonymous
case. This article describes the number and nature of HBV-
infected health care workers in the Netherlands as submitted
to the Committee in the years 2000–2008.
Methods
HBV-infected health care workers
The Committee for Prevention of Iatrogenic Hepatitis B
considered the nature of the professional activities and
reviewed the HBV-related laboratory test results of all
HBV-infected health care workers that were submitted. The
confidential database containing the reviews and test results
of the submitted cases was accessed only by members of
the Committee, thus guaranteeing the privacy of the persons
involved. All HBV-infected health care workers were placed
into one of the following three categories: performing EPPs,
not performing EPPs, or potentially performing EPPS in the
future. The latter category applied to medical students who
do not yet perform invasive procedures. Although medical
interns in the Netherlands in general do not perform EPPs,
medical interns were categorized as 'performing EPPs',
because they unexpectedly may encounter exposure prone
situations.
For this report, all HBV DNA test results expressed in
international units were converted from IU/ml to copies/ml,
assuming that 1 IU equals 5.8 copies of HBV DNA.
Results
Number and nature of HBV-infected health care workers
From 2000–2008, 99 cases of HBV-infected health care
workers were submitted to the Committee for reviewing
and advice. Fifty of the 99 HBV-infected health care
workers performed EPPs (see Table 1). Seven of 99 were
medical students who may perform EPPs in the future, and
42 were categorized as not performing EPPs, which included
general practitioners, a nuclear physician, a pulmonologist, a
geriatric doctor, nurses, technicians, researchers, drivers,
janitors, etc. The 50 EPP performing persons included 20
medical specialists (of which seven were still in training),
nine dentists (four in training), 11 medical interns, three
midwives, two operating room assistants, two dentistry
assistants, two dental hygienists, and one surgical intensive
care nurse.
Eleven of the 50 EPP performing persons had a viral
load above the Dutch threshold level (100,000 HBV DNA
copies/ml); hence they were no longer allowed to perform
EPPs. Twenty-five persons had a HBV DNA load below
the threshold value, enabling them to perform EPPs provided
that their HBV DNA load is monitored. The duration of
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(median 54 months). Monitoring of HBV DNA did not take
place in 14/50 persons because they stopped working,
moved abroad, died, or changed profession. In the 25
persons undergoing monitoring of HBV DNA, the highest
level of HBV DNA encountered during follow-up was as
follows: below 1,000 copies/ml in 4/25 persons, between
1000 and 10,000 copies/ml in 10/25 persons, and between
10,000 and 100,000 copies/ml in 11/25 persons. Table 2
shows the number of restricted persons if other HBV DNA
threshold levels would have been applied.
According to the Dutch guideline, HBV-infected persons
may perform EPPs again if antiviral therapy forces the
HBV load below 100,000 copies/ml, provided that three-
monthly monitoring of HBV DNA takes place. In five of
the 11 restricted cases the ban could be lifted because of
successful antiviral therapy. In one of the 11 restricted cases
the HBV DNA level initially was low. During follow-up the
level of HBV DNA increased, exceeding the threshold
value and necessitating a ban on EPPs.
One of the four dentistry students had a high HBV load
and initially was prohibited to carry out EPPs, which meant
that the training had to be postponed. Later on, successful
antiviral treatment enabled continuation of the study. Never-
theless, the dentistry students, medical students, medical
interns and medical-specialists-in-training were advised to
consider a non-EPP profession, because the possibility of
them developing a high viral load in the future could not be
excluded.
Discussion
Over a period of nine years, from 2000 to 2008, 99 HBV-
infected health care workers were reported to the Committee
for prevention of iatrogenic hepatitis B in the Netherlands. A
ban on performing EPPs had to be imposed in eleven cases.
The Committee continues to receive requests for advice on
HBV-infected personnel, but the number of submitted health
care workers decreased after 2004 (see Table 1). This can be
attributed to the fact that most 'prevalent' HBV-infected
persons have been detected and only new 'incident' cases
are to be reviewed. In addition, local officials have learned
to determine which health care workers certainly do not
perform EPPs and thus are not to be submitted for review
by the Committee.
It is unknown how many HBV-infected, EPP-performing
health care workers went unreported. To investigate
whether the safety of patients was sufficiently safeguarded
with regard to the prevention of hepatitis B, and to enforce
reporting, in 2002 and 2003 the Dutch Health Care
Inspectorate sent a standardised questionnaire on the local
HBV vaccination status and testing policy to all hospitals,
independent treatment centres and private clinics in the
Netherlands. Responses to the questionnaire showed that
75% of the institutions lacked an effective HBV prevention
policy. Subsequently, a representative of the Dutch Health
Care Inspectorate (author B-M) visited selected hospitals,
checking local vaccination and control procedures and
explaining the liability if the Guideline appeared not to be
HBV DNA threshold level (copies/ml) Percentage of restricted personnel
100,000 31% (11/36)
10,000 61% (22/36)
1000 89% (32/36)
Table 2 Number of HBV-
infected health care workers
excluded from exposure prone
procedures according to various
HBV DNA threshold levels
HBV hepatitis B virus
Year Personnel
Performing EPPs Potentially performing
EPPs in future
Not performing EPPs Total
2000 12 0 15 27
2001 9 0 8 17
2002 4 0 5 9
2003 7 2 8 17
2004 8 2 4 14
2005 3 0 2 5
2006 2 3 0 5
2007 3 0 0 3
2008 2 0 0 2
Total 50 7 42 99
Table 1 Number and nature of
HBV-infected health care work-
ers as submitted to and reviewed
by the Dutch Committee for
prevention of iatrogenic
hepatitis B
HBV hepatitis B virus, EPP
exposure prone procedure
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hospitals had their prevention policies in order. Since 2005,
all hospitals, independent treatment centres, and private
clinics known to the Dutch Health Care Inspectorate adhere
to the Dutch guideline on prevention of iatrogenic hepatitis
B. In conclusion, the exact residual risk probably is low, but
remains unknown. The level of HBV viremia in the health
care workers who continued to perform EPPs while being
monitored varied considerably from person to person.
Threshold levels, above which EPPs are prohibited, vary
from country to country [5]. If the European consensus
threshold level (10,000 HBV DNA copies/ml) would have
been applied in the Netherlands, the number of restricted
workers would have doubled. Application of the British
threshold level (1000 copies/ml) would have nearly tripled
the number of restrictions (see Table 2). Unfortunately, it
remains unknown how these different threshold values
affect the safety of patients, as no follow-up takes place of
patients undergoing EPPs by HBV-infected personnel.
During the last decade inhibitors of HBV polymerase
gradually became available for treatment of chronic HBV
infection. Lamivudine and adefovir were approved by the
Federal Drug Administration in 1998 and 2002, and received
marketing authorization for the European Union in 1999 and
2003. Unfortunately, these early HBV inhibitors frequently
cause the emergence of drug-resistant HBV variants [8, 9].
Hence, in the first years of the Committee's existence, long-
term medically maintained suppression of HBV replication
did not seem a solution for highly viremic, EPP performing
personnel. More recent HBV inhibitors like entecavir and
tenofovir display a much more favourable resistance profile
[10, 11]. Buster et al. have shown that prolonged antiviral
therapy for HBV-infected health care workers is a viable
option instead of work restriction, provided that the level of
HBV DNA is monitored regularly [12]. Indeed in five cases
the ban on EPPs could be lifted, because of successful
suppression of HBV. More cases are expected to follow.
Nevertheless, it remains questionable whether highly viremic
dentistry students and surgeons in training should rely on
long-term antiviral medication. The future will tell whether a
switch to a non-exposure prone profession would have been
wiser.
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